Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Mosapride Citrate 5 mg Tablet vs GASMOTIN in Healthy Thai Volunteers (Fasting)
TCTR20240715011Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of mosapride (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
mosapride
Beyond the preview
Go deeper on TCTR20240715011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240715011.